TRV earnings analysis
What we found in TRV's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Travelers reported a strong operating quarter with revenue of $11,924 million (up $114 million vs. Q1 2025) and net income of $1,711 million (diluted EPS $7.78), driven by recovery in Personal Insurance and higher investment income. Operating cash flow improved to $2,198 million and the company closed the previously announced Canadian divestiture (proceeds $2,384 million). Offsetting positives: large unrealized investment mark-to-market losses increased accumulated other comprehensive loss to $(3,078) million and the company repurchased $1,785 million of stock in the quarter, reducing cash to $615 million.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Strong profitability and EPS beat
- Net income was $1,711 million (diluted EPS $7.78) vs. $395 million (diluted EPS $1.70) in Q1 2025 — an increase of $1,316 million and EPS improvement of $6.08 (+~358% YoY).
- Revenue modestly higher YoY
- Total revenues were $11,924 million in Q1 2026, up $114 million (1.0%) from $11,810 million in Q1 2025.
- Segment recoveries — Personal Insurance swung to profit
- Personal Insurance segment income was $704 million in Q1 2026 compared with a loss of $(374) million in Q1 2025 (a positive swing of $1,078 million); Personal segment revenues were $4,323 million vs. $4,457 million a year ago.
- Improved operating cash generation
- Net cash provided by operating activities increased to $2,198 million in Q1 2026 from $1,360 million in Q1 2025 (+$838 million).
- Closed Canadian divestiture, significant proceeds
- Proceeds from the divestiture of the Canadian business of $2,384 million were recorded in Q1 2026 (sale closed January 2, 2026).
- Business and Bond & Specialty segment profitability
- Business Insurance segment income rose to $839 million (from $683 million a year ago) and Bond & Specialty segment income rose to $254 million (from $220 million a year ago).
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Large unrealized investment losses / AOCI deterioration
- Other comprehensive loss (net of tax) was $(578) million for Q1 2026; accumulated other comprehensive loss increased to $(3,078) million at March 31, 2026 from $(2,500) million at December 31, 2025 — driven in part by 'having no credit losses recognized' unrealized investment losses of $(1,146) million reported in Q1 2026.
- Material quarterly catastrophe and reserve activity remains
- Catastrophe losses totaled $761 million in Q1 2026 (Business $379M; Personal $374M) and claims and claim adjustment expense reserves increased to $66,912 million at March 31, 2026 (up $1,175 million from $65,737 million at December 31, 2025).
- Cash down after returns of capital
- Cash (including restricted cash) decreased to $615 million at March 31, 2026 from $842 million at December 31, 2025 (down $227 million), driven by share repurchases of $1,785 million and net financing outflows of $2,085 million in the quarter.
- Increased reinsurance payables / ceded unearned premiums
- Payables for reinsurance premiums increased to $1,123 million at March 31, 2026 from $529 million at December 31, 2025 (+$594 million); ceded unearned premiums rose to $1,877 million from $1,283 million (+$594 million).
- Share repurchase pace reduces equity base
- Treasury stock, at cost, increased to $(47,432) million at March 31, 2026 from $(45,447) million at December 31, 2025 (net share repurchases under authorizations were $1,800 million per the statement of changes), contributing to a decline in total shareholders' equity to $31,986 million (down $908 million).
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $7.78
- Gross margin
- 31.7%
- Operating margin
- 18.7%
- Segment
- Business Insurance — total segment revenues $6,416 million (Q1 2026) vs. $6,311 million (Q1 2025), +$105 million (+1.7%); segment income $839 million (Q1 2026) vs. $683 million (Q1 2025), +$156 million.
- Segment
- Bond & Specialty Insurance — total segment revenues $1,136 million (Q1 2026) vs. $1,103 million (Q1 2025), +$33 million (+3.0%); segment income $254 million (Q1 2026) vs. $220 million (Q1 2025), +$34 million.
- Segment
- Personal Insurance — total segment revenues $4,323 million (Q1 2026) vs. $4,457 million (Q1 2025), -$134 million (-3.0%); segment income $704 million (Q1 2026) vs. $(374) million (Q1 2025) — swing of +$1,078 million.
What they said about what is next.
The Form 10-Q does not provide explicit numeric forward guidance. MD&A/disclosures note the closed sale of the Canadian business (proceeds ~$2.4 billion) and state the FASB internal-use software guidance adopted in 2028 is 'not expected to have a material effect'; no quantitative 2026 outlook was provided in the filing — outlook deferred to earnings release/call.
The filing reads about the same as the one before it.
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing TRV makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever